Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Feb;25(2):234-7.
doi: 10.1128/AAC.25.2.234.

Relation between aminoglycoside 2"-O-nucleotidyltransferase activity and aminoglycoside resistance

Relation between aminoglycoside 2"-O-nucleotidyltransferase activity and aminoglycoside resistance

G P Bongaerts et al. Antimicrob Agents Chemother. 1984 Feb.

Abstract

The relationship between plasmid-coded aminoglycoside 2"-O-nucleotidyltransferase [ANT(2")] activity and the minimum inhibitory concentration for aminoglycosides was studied. ANT(2") was very unstable, and therefore, procedures for handling this enzyme were optimized. Escherichia coli L58058.1 producing ANT(2") was resistant to gentamicin, sisomicin, kanamycin, tobramycin, and dibekacin but susceptible to netilmicin, amikacin, and neomycin. However, only amikacin and neomycin were not modified by ANT(2"). A correlation between the substrate profile of the enzyme tested at 0.15 mM and the minimum inhibitory concentrations of the aminoglycosides could not be demonstrated. The substrate concentration-dependent enzyme activity curves proved to be a better alternative than a substrate profile based on tests at one concentration. At concentrations of greater than 10(-2) mM, ANT(2") demonstrated substrate inhibition that explains the discrepancy between ANT(2") activity and the minimum inhibitory concentrations. A close correlation was found between the physiological efficiency (Vmax/Km ratio) of ANT(2") and the minimum inhibitory concentrations for the enzyme-producing strain.

PubMed Disclaimer

References

    1. FEBS Lett. 1971 May 20;14(5):293-296 - PubMed
    1. J Infect Dis. 1974 Apr;129(4):391-401 - PubMed
    1. Antimicrob Agents Chemother. 1981 Sep;20(3):344-50 - PubMed
    1. Antimicrob Agents Chemother. 1977 Jun;11(6):1074-6 - PubMed
    1. Antimicrob Agents Chemother. 1980 May;17(5):798-802 - PubMed

MeSH terms

Substances